Comparison of Aaftin gel with Triamcinolone effect in patient with Aphthous ulcer

Comparison of Aaftin gel with Triamcinolone effect in patient with Aphthous ulcer (RCT)

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20180707040375N1

Enrollment

Registered

2018-09-03

Start date

2018-09-15

Completion date

Unknown

Last updated

2018-10-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aphthous Ulcer. Recurrent oral aphthae

Interventions

Intervention 1: Intervention group: aaftin gel, Manufactured by the company Kawoshgaran Salamat Bonyan. This gel contains extracts of Astragalus, Tragacanth and Liquorice, which, by removing the surfa

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Avoid patients with systemic disease

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
The amount of pain and irritation. Timepoint: Before the intervention, 2 hours after the intervention, the second day, the fourth day, the sixth day. Method of measurement: VAS scale.	—

Secondary

Measure	Time frame
Size of the wound. Timepoint: Before the intervention, 2 hours after the intervention, the second day, the fourth day, the sixth day. Method of measurement: Graph paper.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSohrab sarhadi

Sohrab sarhadi

sohrab_sarhadi@yahoo.com+98 21 2645 8502

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026